Goldman Sachs
CARM icon

Goldman Sachs’s Carisma Therapeutics CARM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.1K Buy
+13,026
New +$5.1K ﹤0.01% 5083
2025
Q1
Sell
-21,381
Closed -$8.95K 5096
2024
Q4
$8.95K Buy
+21,381
New +$8.95K ﹤0.01% 4944
2024
Q3
Sell
-232,793
Closed -$354K 4853
2024
Q2
$354K Buy
+232,793
New +$354K ﹤0.01% 4123
2024
Q1
Sell
-10,519
Closed -$30.8K 4756
2023
Q4
$30.8K Sell
10,519
-2,230
-17% -$6.53K ﹤0.01% 4589
2023
Q3
$53.9K Sell
12,749
-14,928
-54% -$63.1K ﹤0.01% 4478
2023
Q2
$243K Buy
+27,677
New +$243K ﹤0.01% 4327
2022
Q4
Sell
-69,014
Closed -$29K 5167
2022
Q3
$29K Sell
69,014
-309,642
-82% -$130K ﹤0.01% 5103
2022
Q2
$307K Sell
378,656
-34,996
-8% -$28.4K ﹤0.01% 4685
2022
Q1
$250K Sell
413,652
-193,210
-32% -$117K ﹤0.01% 4974
2021
Q4
$495K Buy
606,862
+403,606
+199% +$329K ﹤0.01% 4531
2021
Q3
$161K Buy
203,256
+143,779
+242% +$114K ﹤0.01% 4933
2021
Q2
$275K Sell
59,477
-87,509
-60% -$405K ﹤0.01% 4749
2021
Q1
$382K Buy
146,986
+113,067
+333% +$294K ﹤0.01% 4513
2020
Q4
$45K Sell
33,919
-114,498
-77% -$152K ﹤0.01% 4569
2020
Q3
$208K Buy
+148,417
New +$208K ﹤0.01% 4044
2018
Q3
Sell
-19,065
Closed -$37K 4116
2018
Q2
$37K Buy
+19,065
New +$37K ﹤0.01% 4088
2017
Q2
Sell
-15,810
Closed -$35K 4407
2017
Q1
$35K Buy
+15,810
New +$35K ﹤0.01% 4261
2016
Q3
Sell
-13,343
Closed -$22K 4546
2016
Q2
$22K Sell
13,343
-28,483
-68% -$47K ﹤0.01% 4392
2016
Q1
$13K Buy
41,826
+31,242
+295% +$9.71K ﹤0.01% 4416
2015
Q4
$32K Sell
10,584
-11,830
-53% -$35.8K ﹤0.01% 4290
2015
Q3
$54K Sell
22,414
-14,054
-39% -$33.9K ﹤0.01% 4327
2015
Q2
$103K Buy
36,468
+20,955
+135% +$59.2K ﹤0.01% 4288
2015
Q1
$138K Sell
15,513
-475
-3% -$4.23K ﹤0.01% 4053
2014
Q4
$190K Sell
15,988
-831
-5% -$9.88K ﹤0.01% 4002
2014
Q3
$187K Buy
+16,819
New +$187K ﹤0.01% 3983
2014
Q2
Sell
-10,785
Closed -$175K 4392
2014
Q1
$175K Buy
+10,785
New +$175K ﹤0.01% 3991